Insider Title Company Date Price Return Shares Value
Martin Samuel Bates SVP and CFO Celldex Therapeutics, Inc. (CLDX) 2020-06-09 $3.05 1325.2% 9,750 $29,738
Return Profit / (loss) Cost
Total 1325.2% $394,095 $29,738